# A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Dermatosis Papulosa Nigra (DPN)

> **NCT06099080** · PHASE2 · UNKNOWN · sponsor: **DermBiont, Inc.** · enrollment: 10 (estimated)

## Conditions studied

- Dermatosis Papulosa Nigra

## Interventions

- **DRUG:** SM-020 gel 1.0%

## Key facts

- **NCT ID:** NCT06099080
- **Lead sponsor:** DermBiont, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11-07
- **Primary completion:** 2024-07-25
- **Final completion:** 2024-07-25
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2024-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06099080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06099080, "A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Dermatosis Papulosa Nigra (DPN)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06099080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*